Clinical TrialID 6823
Cantharidin Application in Molluscum Patients
NCT03377803
Molluscum Contagiosum
Relationship Network
Interactive first-hop connections across herbs, ingredients, formulas, targets, diseases, symptoms, syndromes, evidence, and monographs.
Click a node to open it in a new tab
Trial: 1Ingredient: 1Links: 1
Arranging relationship network...
Record Fields
Scalar fields from the final clinical_trial record.
- Clinical Trial Id
- 6823
- Evidence Id
- 6823
- Core Evidence Id
- 6823
- Source Clinical Trial Id
- 6813
- Herb2 Clinical Trial Id
- HBCT006813
- Nct Id
- NCT03377803
- Title
- Cantharidin Application in Molluscum Patients
- Status
- Completed
- Phase
- Phase 3
- Study Result
- Yes
- Study Condition
- Molluscum Contagiosum
- Study Type
- Interventional
- Study Design
- Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
- Intervention
- COMBINATION_PRODUCT: VP-102 - Cantharidin, Topical Film Forming Solution|COMBINATION_PRODUCT: Placebo -Topical Film Forming Solution without VP-102
- Intervention Allocation
- Randomized
- Intervention Model
- Parallel
- Intervention Mask
- Quadruple
- Intervention Purpose
- Treatment
- Gender
- All
- Age
- Child, Adult, Older_Adult
- Enrollment
- 262
- Outcome Measure
- Percentage of Subjects Exhibiting Complete Clearance of All Treatable Molluscum Lesions (Baseline and New) on the Day 84 Visit (EOS), Percentage of subjects exhibiting complete clearance of all treatable molluscum lesions (baseline and new) on the Day 84 visit (EOS)., Day 1 (Baseline) compared to Day 84 (EOS)
- Sponsor Collaborator
- Verrica Pharmaceuticals Inc.|Instat Consulting, Inc.|Paidion Research, Inc.|Database Integrations, Inc.
- Funded By
- INDUSTRY
- Location
- Bakersfield Dermatology, Bakersfield, California, 93309, United States|Rady Children's Hospital, San Diego, California, 92123, United States|Redwood Family Dermatology, Santa Rosa, California, 95403, United States|Solution Through Advanced Research, Jacksonville, Florida, 32256, United States|Lenus Research and Medical Group, Sweetwater, Florida, 33172, United States|Northwestern Memorial Hospital, Chicago, Illinois, 60611, United States|Dermatology Center of Northwestern Indiana, Crown Point, Indiana, 46307, United States|Pedia Research, Evansville, Indiana, 47715, United States|Pedia Research, Owensboro, Kentucky, 42301, United States|Hamzavi Dermatology, Fort Gratiot, Michigan, 48059, United States|Midwest Children's Health-Northwoods, Lincoln, Nebraska, 68505, United States|Midwest Children's Health, Lincoln, Nebraska, 68505, United States|Tekton Research, Austin, Texas, 78745, United States|DCOL Center for Clinical Research, Longview, Texas, 75605, United States|The Education and Research Foundation, Lynchburg, Virginia, 24501, United States
- Other Id
- VP-102-102
- Start Date
- 2018-02-14
- Primary Completion Date
- 2018-09-26
- Completion Date
- 2018-09-26
- First Posted
- 2017-12-19
- Results First Posted
- 2021-12-14
- Last Update Posted
- 2021-12-14
- Study Document
- Study Protocol, https://cdn.clinicaltrials.gov/large-docs/03/NCT03377803/Prot_000.pdf|Statistical Analysis Plan, https://cdn.clinicaltrials.gov/large-docs/03/NCT03377803/SAP_001.pdf
- Study Url
- https://clinicaltrials.gov/study/NCT03377803
- Title Cn
- Title En
- Cantharidin Application in Molluscum Patients
- Bilingual Status
- semi_complete